| 08:30-08:50 | Registration |
| 08:50-09:00 | Opening Remark |
| | Session I-1.NGS
좌장 : 이건국 (국립암센터) | Session I-2. Lung cancer genomics좌장 : 장세진 (울산의대) |
|---|
| 09:00-09:20 | NGS기반 유전자 패널검사의 질관리손대순 (삼성유전체 연구소) | 09:00-09:30 | NGS data -based Artificial Intelligence Model for Cancer-Drug-Response Profiling 정종선 (신테카 바이오) |
| 09:20-09:40 | NGS 기반 유전자 패널 검사 급여화 배경 및 전망심효섭 (연세의대) | 09:30-10:00 | Study for cancer genomics; whats left?김주한 (서울대) |
| 09:40-10:00 | NGS 기반 유전자 패널 검사의 기관별 상황 및 전망 I김지훈 (울산의대) | 10:00-10:30 | Genomic data sharing; implications & hurdles정연준(가톨릭의대) |
| 10:00-10:20 | NGS 기반 유전자 패널 검사의 기관별 상황 및 전망 II김태정 (가톨릭의대) | |
| 10:20-10:30 | Q&A | |
| 10:30-11:00 | Coffee Break |
| | Plenary Session 좌장 : 조문준 (충남의대) |
|---|
| 11:00-11:50 | The Healthcare Innovation for the precision cancer medicine with IBM Watson Health? Annette Hicks (Watson Health, IBM) |
| 11:50-12:00 | Q&A |
| | Luncheon Symposium I좌장 : 김상위 (울산의대) |
|---|
| 12:00-12:40 | Big Stride in 1L NSCLC treatment: moving from chemotherapy to anti- PD 1 therapy (MSD)Raffaele Califano
(The Christie NHS Foundation Trust and University Hospital of South Manchester) |
| 12:40-13:00 | Coffee Break |
| | Oral Presentation |
|---|
| 13:00~13:10 | Chemopreventive effect of long-term use of low-dose aspirin on lung cancer risk A nationwide study considering competing risk
천은미 (이화의대) | 13:00~13:10 | Weekly Docetaxel as first-line chemotherapy in elderly patients with advanced squamous cell non-small cell lung cancer : phase II study
최종현 (고려의대) | 13:00~13:10 | 폐암 환자를 대상으로 개인 맞춤형 호흡 재활 서비스(숨튼 PHR®)의 임상적 효과를 확인하기 위한 전향적 연구
지원준 (울산의대) |
| 13:10~13:20 | Bone Metastasis is associated with Osteoporosis Risk Among Lung Cancer Patients
이승룡 (고려의대) | 13:10~13:20 | Increased Response Rates to Salvage Chemotherapy Administered after PD-1/PD-L1 Inhibitors in Patients with Non-Small Cell Lung Cancer
박송이 (성균관의대) | 13:10~13:20 | Generative Model of Functional RT-Plan Chest CT for Lung Cancer Patients Using Machine Learning Algorithm
장범섭 (서울의대) |
| 13:20~13:30 | Role of low-dose computerized tomography in lung cancer screening among never-smokers
강혜린 (서울의대) | 13:20~13:30 | Clinical characteristics of lung cancer with programmed death-ligand 1 expression
박하영 (전남의대) | 13:20~13:30 | Generation of predicted tumor-regression computed tomography image during definitive concurrent chemo-radiotherapy of the lung cancer using deep learning technique
김경수 (동남권원자력의학원) |
| 13:30~13:40 | Comparison of PD-L1 Expression on Cell Block and Matched Resection Specimens from Lung Cancer
노미숙 (동아의대) | 13:30~13:40 | Continuing Gefitinib beyond progression in patients with EGFR Mutation-Positive Non-Small-Cell Lung Cancer: A phase II single-arm prospective trial
임성원 (성균관의대) | 13:30~13:40 | Initial PET/CT maximal SUV as a Biologic Predictive Factor Prognostic of Outcome in Early-stage NSCLC after SABR
곽유강 (가톨릭의대) |
| 13:40~13:50 | Extracellular vesicle DNA for liquid biopsy
허재영 (건국의대) | 13:40~13:50 | Outcomes of T790M+ lung cancer patients treated with osimertinib in real world practice after acquired resistance to the previous EGFR-TKI in Korea
오동규 (울산의대) | 13:40~13:50 | Exosomes Increase More at Pulmonary Vein than Peripheral Vessel in Lung Cancer: based on preclinical and clinical studies
김현구 (고려의대) |
| 13:50~14:00 | Detection and dynamic change of EGFR mutation status in plasma and comparison of tissue from NSCLC patients
이윤경 (울산의대) | 13:50~14:00 | Phase II Trial of AZD9291 in Second-Line Treatment after Acquired Resistance with T790M Mutation Detected From Circulating Tumor DNA (LiquidLung-O-Cohort 2)
김영철 (전남의대) | 13:50~14:00 | Prognostic Factor and Survival of Patients with Resected stage IIIA N2 Lung Adenocarcinoma
김제훈 (울산의대) |
| 14:00~14:10 | Feasibility and alternative approaches of rebiopsy in non-small cell lung cancer patients treated with epidermal growth factor receptor tyrosine kinase inhibitors
김희정 (건국의대) | 14:00~14:10 | Tumor-derived microvesicles promote the immune surveillance of tumor through PD-1/PD-L1 interaction
김동하 (울산의대) | 14:00~14:10 | Feasibility of lobectomy and mediastinal node dissection by video-assisted thoracoscopic surgery following neoadjuvant?chemoradiaotherapy for stage IIIA N2?lung cancer: Propensity matching analysis
전영정 (성균관의대) |
| 14:10~14:20 | Feasibility of Liquid Biopsy Using Plasma and Platelets for Detection of ALK Rearrangements in Non-Small Cell Lung Cancer
박철규 (전남의대) | 14:10~14:20 | Glucose Supports EGFR-mutant Lung Adenocarcinoma Cell Survival by Inhibiting Autophagy-mediated EGFR Degradation
노진경 (울산의대) | 14:10~14:20 | Diffusing capacity(DLco) decrement following neoadjuvant concurrent chemoradiotherapy :implication on postoperative pulmonary complications in lung cancer patients
신수민 (성균관의대) |
| 14:20-14:40 | Coffee Break |
| | Session II-1. In-depth review of 8th TNM staging
좌장 : 이춘택 (서울의대) | Session II-2. Screen-detected Ground Glass Nodules좌장 : 나국주 (전남의대) | Session II-3. Emerging field of Radiomics
좌장 : 용환석 (고려의대) |
|---|
| 14:40-15:05 | TNM staging; pulmonologists
perspective황보빈 (국립암센터) | 14:40-15:00 | Management strategy and guideline: follow-up vs. surgery전재현 (국립암센터) | Basics of image processing in radiomics 김남국 (울산의대) |
| 15:05-15:30 | TNM staging;
radiologists perpective안명임 (가톨릭의대) | 15:00-15:20 | Preoperative workup: Bronchoscopy/EBUS, brain MRI, PET/ CT, Biopsy are needed?조정수 (부산의대) | Radiomics: the current status이호연 (성균관의대) |
| 15:30-15:55 | TNM staging; surgeons perspective이진구 (연세의대) | 15:20-15:40 | Localization technique조석기 (서울의대) | Radiomics and beyond: limitations and future directions박창민 (서울의대) |
| 15:55-16:10 | Q&A | 15:40-16:00 | Surgical procedure: Optimal extent of pulmonary resection
and mediastinal LN assessment김홍관 (성균관의대) | Q&A |
| 16:00-16:10 | Q&A | |
| 16:10-16:40 | Coffee Break |
| | Session III-1. Neuroendocrine
tumors other than SCLC좌장 : 김관민 (서울의대) | Session III-2. Thymic Epithelial Tumors
좌장 : 오영택 (아주의대) | Session III-3. SCLC
좌장 : 안명주 (성균관의대) |
|---|
| 16:40-17:00 | Pathology of neuroendocrine tumor하승연 (가천의대) | Review of staging and pathologic classification노미숙 (동아의대) | Novel chemotherapeutic agent in SCLC김혜련 (연세의대) |
| 17:00-17:20 | Surgery김형렬 (울산의대) | Recent updates of chemotherapy안희경 (가천의대) | Role of radiation therapy in extensive disease SCLC김학재 (서울의대) |
| 17:20-17:40 | Chemotherapy for large cell neuroendocrine carcinoma선종무 (성균관의대) | Radiotherapy for Thymic Tumors송상혁 (강원의대) | Role of surgery in SCLC이호석 (부산의대) |
| 17:40-18:00 | Coffee Break |
| | Dinner Symposium (Sapphire room)좌장 : 김영철 (전남의대) |
|---|
| 18:00-18:50 | Recent update with clinical practice of Atezolizumab in NSCLC (Roche)한지연 (국립암센터) |